d) Cell Therapy & Oncology at Gilead Sciences

Munich, Bavaria, Germany

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Oncology, BiotechnologyIndustries

Requirements

Master’s degree in Biostatistics and profound knowledge in Market Access
3+ years of experience in Biotech, Pharma or healthcare organizations with a focus on Market Access
Excellent understanding and application of statistical methods defined by G-BA and IQWiG
Outstanding analytical, methodological, and strategic capabilities
Good understanding of Market Access processes, especially the AMNOG process
HEOR skills (e.g., design and conduction of HEOR studies, modelling) are a plus
Good understanding of German health care system, ideally knowledge about international health care system archetypes
Excellent technical and social skills

Responsibilities

Leading and supporting preparations for the AMNOG process (early advice meetings, value dossier preparation, oral hearings)
Conducting pricing exercises, contributing to price negotiations with GKV-SV
Providing input into clinical development to ensure optimal reimbursement and launch readiness for the respective product
Advice on biostatistical needs, with a focus on AMNOG
Ensuring pricing analysis and modelling, support of price databases
Design, conduction and publication of HEOR studies, including RWD
Collaboration with local Market Access, Medical, Regulatory, Government and Public Affairs colleagues, Global HEOR and Value & Access colleagues
Defining and implementing comprehensive market access strategies with a focus on products within Cell Therapy and Oncology

Skills

Market Access

Oncology

Cell Therapy

Pricing Strategy

Reimbursement

Health Economics

Stakeholder Management

Cross-functional Collaboration

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free